For the first time in more than a decade, the FDA has approved a new medication for people with Secondary Progressive Multiple Sclerosis.
That's a hard-to-treat form that affects long-term MS patients.
Drugs which worked in earlier stages can lose their effectiveness over time, affecting a patient's ability to walk, use their arms and even think.
In tests, patients on the new drug Siponimod progressed more slowly than those taking a placebo.
Doctors say it's not a cure yet, but is an important step in treating MS.
Follow us on YouTube
Send a News Tip to Action News
Learn More About 6abc Apps
FDA approves new MS medication for first time in over a decade
More TOP STORIES News